NADPH oxidase activity is associated with cardiac osteopontin and pro-collagen type I expression in uremia

References

• Loos-Ayav C, Briancon S, Frimat L, Andre JL, Kessler M. Incidence of chronic kidney disease in general population, EPIRAN study. Nephrol Ther 2009;5(Suppl 4):250–255.
   Google Scholar
• Terrier N, Senecal L, Dupuy AM, Jaussent I, Delcourt C, Leray H, Rafaelsen S, Bosc JY, Maurice F, Canaud B, Cristol JP. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients. Hemodial Int 2005;9:159–168.
   PubMedGoogle Scholar
• Nanayakkara PW, Gaillard CA. Vascular disease and chronic renal failure: new insights. Neth J Med 2010;68:5–14.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 42:864–881.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000;15:953–960.
   PubMed Web of Science ®Google Scholar
• Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005;9:37–46.
   PubMedGoogle Scholar
• Kunz K, Dimitrov Y, Muller S, Chantrel F, Hannedouche T. Uraemic cardiomyopathy. Nephrol Dial Transplant 1998;13 (Suppl 4):39–43.
   Google Scholar
• Lopez B, Gonzalez A, Hermida N, Laviades C, Diez J. Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide. Kidney Int Suppl 2008;(111)74:19–23.
   Google Scholar
• Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, Klingel K. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ Res 2009;104:851–859.
   PubMed Web of Science ®Google Scholar
• Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245–313.
   PubMed Web of Science ®Google Scholar
• Feillet-Coudray C, Sutra T, Fouret G, Ramos J, Wrutniak-Cabello C, Cabello G, Cristol JP, Coudray C. Oxidative stress in rats fed a high-fat high-sucrose diet and preventive effect of polyphenols: involvement of mitochondrial and NAD(P)H oxidase systems. Free Radic Biol Med 2009;46:624–632.
   PubMed Web of Science ®Google Scholar
• Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signalling. Curr Med Chem 2004;11:1163–1182.
   PubMed Web of Science ®Google Scholar
• Cave A, Grieve D, Johar S, Zhang M, Shah AM. NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology. Philos Trans R Soc Lond B Biol Sci 2005;360:2327–2334.
   PubMedGoogle Scholar
• Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008;3:505–521.
   PubMed Web of Science ®Google Scholar
• Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006;70:1577–1583.
   PubMed Web of Science ®Google Scholar
• Stockelman MG, Lorenz JN, Smith FN, Boivin GP, Sahota A, Tischfield JA, Stambrook PJ. Chronic renal failure in a mouse model of human adenine phosphoribosyltransferase deficiency. Am J Physiol 1998;275:154–163.
   Web of Science ®Google Scholar
• Sreejith P, Narasimhan KL, Sakhuja V. 2, 8 Dihydroxyadenine urolithiasis: a case report and review of literature. Indian J Nephrol 2009;19:34–36.
   Google Scholar
• Yokozawa T, Zheng PD, Oura H. Experimental renal failure rats induced by adenine – Evaluation of free amino acid, ammonia nitrogen and guanidino compound levels. Agric Biol Chem 1983;47:2341–2348.
   Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
   PubMed Web of Science ®Google Scholar
• Yagi K. Assay for blood plasma or serum. Methods Enzymol 1984;105:328–331.
   PubMed Web of Science ®Google Scholar
• Sunderman FW, Jr, Marzouk A, Hopfer SM, Zaharia O, Reid MC. Increased lipid peroxidation in tissues of nickel chloride-treated rats. Ann Clin Lab Sci 1985;15:229–236.
   PubMed Web of Science ®Google Scholar
• Marklund S. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J Biol Chem 1976;251:7504–7507.
   PubMed Web of Science ®Google Scholar
• Beers RF, Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952;195:133–140.
   PubMed Web of Science ®Google Scholar
• Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114–121.
   PubMed Web of Science ®Google Scholar
• Janssen AJ, Trijbels FJ, Sengers RC, Smeitink JA, van den Heuvel LP, Wintjes LT, Stoltenborg-Hogenkamp BJ, Rodenburg RJ. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 2007;53:729–734.
   PubMed Web of Science ®Google Scholar
• Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray JM, Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35–51.
   PubMed Web of Science ®Google Scholar
• Wharton DC, Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol 1967;10:245–250.
   Google Scholar
• Srere P. Citrate synthase. Methods Enzymol 1969;13:3–11.
   Google Scholar
• Sutra T, Oiry C, Azay-Milhau J, Youl E, Magous R, Teissedre PL, Cristol JP, Cros G. Preventive effects of nutritional doses of polyphenolic molecules on cardiac fibrosis associated with metabolic syndrome: involvement of osteopontin and oxidative stress. J Agric Food Chem 2008;56:11683–11687.
   Google Scholar
• Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072–1083.
   PubMed Web of Science ®Google Scholar
• de Simone G, Wallerson DC, Volpe M, Devereux RB. Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation. Am J Hypertens 1990;3:688–696.
   Google Scholar
• Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 1987;9: 19–26.
   Web of Science ®Google Scholar
• Slama M, Susic D, Varagic J, Ahn J, Frohlich ED. Echocardiographic measurement of cardiac output in rats. Am J Physiol Heart Circ Physiol 2003;284:691–697.
   PubMed Web of Science ®Google Scholar
• Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, Smetana S. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 1999;56: 1078–1083.
   PubMed Web of Science ®Google Scholar
• Husain K, Ferder L, Mizobuchi M, Finch J, Slatopolsky E. Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats. Am J Nephrol 2009;29:465-472.
   PubMed Web of Science ®Google Scholar
• Chaudiere J, Ferrari-Iliou R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 1999;37:949–962.
   PubMed Web of Science ®Google Scholar
• Singh M, Foster CR, Dalal S, Singh K. Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI. J Mol Cell Cardiol 2010;48:538–543.
   PubMed Web of Science ®Google Scholar
• Bendall JK, Cave AC, Heymes C, Gall N, Shah AM. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 2002;105:293–296.
   PubMed Web of Science ®Google Scholar
• Okamoto H. Osteopontin and cardiovascular system. Mol Cell Biochem 2007;300:1–7.
   PubMed Web of Science ®Google Scholar
• Schellings MW, Pinto YM, Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res 2004;64:24–31.
   PubMed Web of Science ®Google Scholar
• McCurdy S, Baicu CF, Heymans S, Bradshaw AD. Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC). J Mol Cell Cardiol 2010;48:544–549.
   PubMed Web of Science ®Google Scholar
• Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 2004;287:264–273.
   PubMed Web of Science ®Google Scholar
• Delbosc S, Cristol JP, Descomps B, Mimran A, Jover B. Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress. Hypertension 2002;40:142–147.
   PubMed Web of Science ®Google Scholar
• Rugale C, Delbosc S, Mimran A, Jover B. Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine. J Cardiovasc Pharmacol 2007;50:293–298.
   PubMed Web of Science ®Google Scholar
• Amann K, Tornig J, Buzello M, Kuhlmann A, Gross ML, Adamczak M, Ritz E. Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure. Kidney Int 2002;62:877–884.
   Google Scholar